Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.97 |
| ▸ | BLM | P54132 | 1/20 | 0.97 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.44 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | BCHE | P06276 | 4/20 | 0.39 |
| ▸ | ACHE | P22303 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29389684 | 1.00 | TSHR (1.00) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 | |
| Hydrochloric Acid SCHEMBL2268042 | 0.98 | LMNA (1.00) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 | |
| Hydrochloric Acid SCHEMBL29390714 | 0.98 | LMNA (1.00) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 | |
| SCHEMBL4049148 | 0.85 | TSHR (0.81) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 | |
| SCHEMBL13137718 | 0.81 | MAPT (0.97) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 | |
| SCHEMBL8483664 | 0.77 | TSHR (0.67) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 | |
| SCHEMBL22340503 | 0.76 | TSHR (0.67) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 | |
| Hydrochloric Acid SCHEMBL29455712 | 0.76 | MAPT (0.65) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 | |
| SCHEMBL8021687 | 0.74 | TSHR (0.59) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 | |
| Hydrochloric Acid SCHEMBL5108270 | 0.73 | MAPT (0.62) | TSHRCYP1A2CYP2D6CYP2C19NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250058091-A1 | TREATMENT OF HYPERTENSION BY RENAL VASCULAR DELIVERY OF GUANETHIDINE | MERCATOR MEDSYSTEMS, INC. | 2025-02-20 | — | — | US | claimed |
| EP-2768514-A1 | LOCALIZED MODULATION OF TISSUES AND CELLS TO ENHANCE THERAPEUTIC EFFECTS INCLUDING RENAL DENERVATION | Mercator Medsystems, Inc. (US) | 2014-08-27 | — | — | EP | claimed |
| US-20130252932-A1 | LOCALIZED MODULATION OF TISSUES AND CELLS TO ENHANCE THERAPEUTIC EFFECTS INCLUDING RENAL DENERVATION | MERCATOR MEDSYSTEMS, INC. (US) | 2013-09-26 | — | — | US | claimed |
| WO-2013059735-A1 | LOCALIZED MODULATION OF TISSUES AND CELLS TO ENHANCE THERAPEUTIC EFFECTS INCLUDING RENAL DENERVATION | MERCATOR MEDSYSTEMS, INC. (US) | 2013-04-25 | — | — | WO | claimed |
| US-12496469-B2 | Devices and methods for endoluminal delivery of either fluid or energy for denervation | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| US-20250339496-A1 | SYSTEMS AND METHODS FOR SYMPATHETIC CARDIOPULMONARY NEUROMODULATION | TULAVI THERAPEUTICS INC (US) | 2025-11-06 | — | — | US | disclosed |
| EP-3288626-B1 | SUBSTANCES AND COMPOSITIONS FOR USE IN BLOCKING NERVE REGENERATION | REFLEX MEDICAL INC (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250288728-A1 | SYSTEMS AND METHODS FOR GEL-BASED NEUROMODULATION | TULAVI THERAPEUTICS INC (US) | 2025-09-18 | — | — | US | disclosed |
| US-20250127964-A1 | SYSTEMS AND METHODS FOR GEL-BASED NEUROMODULATION | TULAVI THERAPEUTICS INC (US) | 2025-04-24 | — | — | US | disclosed |
| US-20250058091-A1 | TREATMENT OF HYPERTENSION BY RENAL VASCULAR DELIVERY OF GUANETHIDINE | MERCATOR MEDSYSTEMS, INC. | 2025-02-20 | — | — | US | disclosed |
| EP-3556749-B1 | LOCALIZED MODULATION OF TISSUES AND CELLS TO ENHANCE THERAPEUTIC EFFECTS INCLUDING RENAL DENERVATION | MERCATOR MEDSYSTEMS INC (US) | 2023-10-04 | — | — | EP | disclosed |
| US-11446359-B2 | Systems and methods for cardiac plexus neuromodulation | Tulavi Therapeutics, Inc. (US) | 2022-09-20 | — | — | US | disclosed |
| EP-0573498-B1 | ALIPHATIC PROPARGYLAMINES AS SELECTIVE MAO-B INHIBITORS AND AS NEUROPROTECTIVE AGENTS | UNIV SASKATCHEWAN (CA) | 1998-11-18 | — | — | EP | disclosed |
| US-5589513-A | TREATMENT OF NEURODEGENERATIVE DISEASES; MONOAMINE OXIDASE INHIBITOR AND UPTAKE INHIBITOR | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1996-12-31 | — | — | US | disclosed |
| US-5508311-A | Aliphatic propargylamines as selective MAO-B inhibitors and as neuroprotective agents | UNIVERSITY OF SASKATCHEWAN (CA) | 1996-04-16 | — | — | US | disclosed |
| EP-0602044-A4 | A CDNA CLONE ENCODING A HUMAN NOREPINEPRHINE TRANSPORTER. | OREGON STATE (US) | 1994-10-05 | — | — | EP | disclosed |
| EP-0602044-A1 | A cDNA CLONE ENCODING A HUMAN NOREPINEPRHINE TRANSPORTER | STATE OF OREGON BY AND THROUGH OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OREGON HEALTH SC. UNIV. AND OREGON STATE UNIV. (US) | 1994-06-22 | — | — | EP | disclosed |
| EP-0573498-A1 | ALIPHATIC PROPARGYLAMINES AS SELECTIVE MAO-B INHIBITORS AND AS NEUROPROTECTIVE AGENTS | UNIVERSITY OF SASKATCHEWAN (CA) | 1993-12-15 | — | — | EP | disclosed |
| WO-1992017568-A1 | A cDNA CLONE ENCODING A HUMAN NOREPINEPRHINE TRANSPORTER | OREGON HEALTH SCIENCES UNIVERSITY (US) | 1992-10-15 | — | — | WO | disclosed |
| WO-1992015551-A1 | ALIPHATIC PROPARGYLAMINES AS SELECTIVE MAO-B INHIBITORS AND AS NEUROPROTECTIVE AGENTS | UNIVERSITY OF SASKATCHEWAN (CA) | 1992-09-17 | — | — | WO | disclosed |